sofosbuvir has been researched along with Kidney Failure in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Calleja, JL; Hernández-Conde, M | 1 |
| Afshar, B; Agah, S; Amiriani, T; Fattahi Abdizadeh, M; Fattahi, MR; Hormati, A; Khoshnia, M; Latifnia, M; Majd Jabbari, S; Maleki, I; Malekzadeh, R; Malekzadeh, Z; Mansour-Ghanaei, F; Merat, D; Merat, S; Minakari, M; Moini, M; Mokhtare, M; Poustchi, H; Roozbeh, F; Sharifi, AH; Shayesteh, AA; Shayesteh, E; Sofian, M; Sohrabi, M; Somi, MH | 1 |
| Kao, JH; Liu, CH | 1 |
| Aggarwal, R; Bhadauria, DS; Goel, A; Gupta, A; Kaul, A; Rai, P; Rungta, S; Tiwari, P; Verma, A | 1 |
| De, A; Kumar, P; Kumari, S; Singh, A; Singh, V | 1 |
| Bonacci, M; Campistol, JM; Esforzado, N; Forns, X; Londoño, MC; Sotoca, JM | 1 |
| Kattakuzhy, S; Kottilil, S; Tang, L; Ward, H; Wilson, E | 1 |
| Craft, ZN; Kamal, KM; Koerner, PH; Miller, RT; Trombatt, WD | 1 |
| Brainard, D; German, P; Kearney, BP; Mathias, A | 1 |
| Al Zoairy, R; Beinhardt, S; Ferenci, P; Freissmuth, C; Hofer, H; Kozbial, K; Maieron, A; Schmidt, A; Stättermayer, AF; Stauber, R; Stern, R; Strasser, M; Trauner, M; Watschinger, B; Zoller, H | 1 |
| Alric, L; Bailly, F; Dumortier, J; Gagnieu, MC; Grangé, JD; Guillaud, O; Habersetzer, F; Kamar, N; Leroy, V; Minello, A; Pageaux, GP; Radenne, S; Vallet-Pichard, A | 1 |
| Deng, G; Li, Q; Liu, D; Ma, J; Meng, S; Peng, L; Shen, S; Wu, J; Zhou, J | 1 |
| Lange, CM; Mücke, MM; Mücke, VT; Zeuzem, S | 1 |
3 review(s) available for sofosbuvir and Kidney Failure
| Article | Year |
|---|---|
Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection.
Topics: Antiviral Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Failure; Liver Transplantation; Recurrence; Renal Insufficiency; Ribavirin; Sofosbuvir | 2016 |
Clinical Pharmacokinetics and Pharmacodynamics of Ledipasvir/Sofosbuvir, a Fixed-Dose Combination Tablet for the Treatment of Hepatitis C.
Topics: Animals; Antiviral Agents; Area Under Curve; Benzimidazoles; Dose-Response Relationship, Drug; Drug Interactions; Fluorenes; Half-Life; Hepatitis C, Chronic; Humans; Hydrogen-Ion Concentration; Liver Failure; Metabolic Clearance Rate; Renal Insufficiency; Sofosbuvir; Sustained Virologic Response; Uridine Monophosphate | 2016 |
Special populations: treating hepatitis C in patients with decompensated cirrhosis and/or advanced renal impairment.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Randomized Controlled Trials as Topic; Renal Insufficiency; Ribavirin; Sofosbuvir; Sustained Virologic Response | 2017 |
10 other study(ies) available for sofosbuvir and Kidney Failure
| Article | Year |
|---|---|
Editorial: clinical impact of sofosbuvir renal toxicity-more light on the way.
Topics: Antiviral Agents; Humans; Renal Insufficiency; Sofosbuvir | 2022 |
The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment.
Topics: Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Hepatitis C; Humans; Imidazoles; Liver Cirrhosis; Male; Pyrrolidines; Renal Dialysis; Renal Insufficiency; Safety; Severity of Illness Index; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine | 2020 |
Reply to: "Sofosbuvir and the risk of kidney dysfunction".
Topics: Antiviral Agents; Hepacivirus; Humans; Kidney; Renal Insufficiency; Sofosbuvir | 2021 |
Acute hepatitis C treatment in advanced renal failure using 8 weeks of pan-genotypic daclatasvir and reduced-dose sofosbuvir.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Renal Insufficiency; Sofosbuvir; Treatment Outcome; Valine; Young Adult | 2021 |
Sofosbuvir with NS5A inhibitors in hepatitis C virus infection with severe renal insufficiency.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Benzimidazoles; Carbamates; Female; Fluorenes; Genotype; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Renal Insufficiency; Sofosbuvir; Treatment Outcome; Valine; Viral Nonstructural Proteins; Young Adult | 2018 |
Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV-decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list.
Topics: Administration, Oral; Allografts; Antiviral Agents; Female; Genotype; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Liver Cirrhosis; Liver Transplantation; Middle Aged; Renal Insufficiency; Simeprevir; Sofosbuvir; Transplant Recipients; Treatment Outcome; Waiting Lists | 2015 |
Retrospective Analysis of the Medication Utilization and Clinical Outcomes of Patients Treated with Various Regimens for Hepatitis C Infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Drug Utilization; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Nausea; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Treatment Outcome; Young Adult | 2017 |
DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Carbamates; Cohort Studies; Drug Therapy, Combination; Female; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Immunosuppressive Agents; Kidney; Kidney Function Tests; Kidney Transplantation; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Period; Preoperative Period; Pyrrolidines; Renal Dialysis; Renal Insufficiency; RNA, Viral; Simeprevir; Sofosbuvir; Valine | 2016 |
Sofosbuvir-based antiviral therapy in hepatitis C virus patients with severe renal failure.
Topics: Antiviral Agents; Female; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Sofosbuvir | 2017 |
Sofosbuvir Monotherapy for Asymptomatic and Noncirrhotic Hepatitis C Infection in a Renal Retransplantation Recipient: A Case Report.
Topics: Antiviral Agents; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney Transplantation; Male; Middle Aged; Renal Dialysis; Renal Insufficiency; Reoperation; Sofosbuvir; Treatment Outcome | 2016 |